Examining a stock’s 52-week price history, encompassing its low and high prices, can reveal much about its existing condition and potential future trajectory. Neumora Therapeutics Inc.’s current trading price is -39.05% away from its 52-week high, while its distance from the 52-week low is 53.66%. The stock’s price range over this period has fluctuated between $8.33 and $21.00. The company, operating within the financial sector, had a trading volume of approximately 0.89 million for the day, which was noticeably higher than the average daily share volume of 0.88 million over the last 3 months.
Neumora Therapeutics Inc.’s market performance has been stable in recent times. The company’s stock hit a 1-year high of $21.00 on 03/08/24 and a low of $8.33 for the same time frame on 06/26/24.
3 Tiny Stocks Primed to Explode
The world's greatest investor — Warren Buffett — has a simple formula for making big money in the markets. He buys up valuable assets when they are very cheap. For stock market investors that means buying up cheap small cap stocks like these with huge upside potential.
We've set up an alert service to help smart investors take full advantage of the small cap stocks primed for big returns.
Click here for full details and to join for free
Sponsored
Exploring Financial Performance and Market Capitalization: A Comprehensive Analysis
Neumora Therapeutics Inc. (NMRA) has experienced a quarterly rise of 48.84% in its revenues when compared to the same period in the previous year. Presently, the company has a total market capitalization of 2.05B and boasts a workforce of 124 employees.
Analyzing Trading Volume and Moving Average Trends
Based on Barchart.com data, the company’s moving average over the 100-day period was 10.80, with a change in price of +3.58. Similarly, Neumora Therapeutics Inc. recorded 761,532 in trading volume during the last 100 days, posting a change of +38.83%.
Understanding Ticker ‘s Debt-to-Equity Ratio: An Analysis
The debt-to-equity (D/E) ratio serves as an important indicator of a company’s financial stability and market position. By dividing a company’s total liabilities by its shareholders’ equity, the D/E ratio reveals the degree to which a company relies on debt to finance assets compared to its shareholders’ equity. At the time of writing, the total D/E ratio for NMRA stands at 0.01. Similarly, the long-term debt-to-equity ratio is also 0.00.
NMRA Stock Stochastic Average
Today, Neumora Therapeutics Inc.’s raw stochastic average for the past 50 days stands at 80.05%, indicating a decline from the raw stochastic average of the last 20 days, which was 85.66%. Moreover, the company’s Stochastic %K and %D values over the past 20 days were 80.54% and 83.56% respectively.
NMRA Stock Price Performance Analysis
The performance of the stock price over the year has been up and down, leaving investors with either an optimistic or pessimistic outlook, depending on how they interpret the data. The index has shown a price loss of -24.93% this year. Over the last six months, there has been a weaker performance of 1.51%. The price of NMRA fallen by 9.31% during the last 30 days period. For the last 5-days stocks have improved 4.83%.
